InsidersTradesSigma
Declaraciones totales
Empresas
▲ Compras (0 oper.)
▼ Ventas (0 oper.)
Browse the complete record of transactions filed by Wengel Kathryn E, Directeur Exécutif. Director active across 2 companies, notably Johnson & Johnson. Aggregated, 5 reports have been recorded. Activity tracked since 14 February 2022. The latest transaction was filed on 10 June 2022 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Wengel Kathryn E
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declaraciones5 en total
40.000 títulos@ 72,54 US$0.0005% mcap100.0% de su flujoCommon StockSEC:0001225208-22-008089:0
603 títulosCommon StockSEC:0001127602-22-010476:0
10.386 títulos0Common StockSEC:0001225208-22-002374
10.386 títulos0Common StockSEC:0001225208-22-002374:0
1896 títulos0Common StockSEC:0001225208-22-002217:0
5 de 5 declaraciones
About Wengel Kathryn E
Kathryn E. Wengel is Executive Vice President and Chief GSC Officer at JOHNSON & JOHNSON and LABORATORY CORP OF AMERICA HOLDINGS. She oversees supply chain operations and cost management strategy. Her role is essential in ensuring efficiency and innovation in the operational processes of the companies.
